Mimedx (MDXG) Capital Expenditures Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 46.88% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.97% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 16.27% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -3.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.43% |
| Dec 31, 2025 | -24.68% |
| Sep 30, 2025 | -18.06% |
| Jun 30, 2025 | -22.19% |
| Mar 31, 2025 | 47.28% |
| Dec 31, 2024 | -6.81% |
| Sep 30, 2024 | -32.13% |
| Jun 30, 2024 | -36.24% |
| Mar 31, 2024 | -16.16% |
| Dec 31, 2023 | -2.67% |
| Sep 30, 2023 | -50.80% |
| Jun 30, 2023 | -9.99% |
| Mar 31, 2023 | -14.45% |
| Dec 31, 2022 | -1.46% |
| Sep 30, 2022 | 30.79% |
| Jun 30, 2022 | 14.83% |
| Mar 31, 2022 | -43.32% |
| Dec 31, 2021 | -43.78% |
| Sep 30, 2021 | -35.61% |
| Jun 30, 2021 | -45.28% |
| Mar 31, 2021 | -14.16% |
| Dec 31, 2020 | 24.08% |
| Sep 30, 2020 | -45.30% |
| Jun 30, 2020 | 334.45% |
| Mar 31, 2020 | 365.85% |
| Dec 31, 2019 | 28.75% |
| Sep 30, 2019 | -53.44% |
| Jun 30, 2019 | -47.62% |
| Mar 31, 2019 | -31.41% |
| Dec 31, 2018 | 3.47% |
| Sep 30, 2018 | 7.21% |
| Jun 30, 2018 | 28.46% |
| Mar 31, 2018 | 31.59% |
| Dec 31, 2017 | -22.98% |
| Sep 30, 2017 | 428.38% |
| Jun 30, 2017 | -44.34% |
| Mar 31, 2017 | -32.83% |
| Dec 31, 2016 | -38.63% |
| Sep 30, 2016 | 17.40% |
| Jun 30, 2016 | 21.28% |
| Mar 31, 2016 | 201.13% |
| Dec 31, 2015 | 91.49% |
| Sep 30, 2015 | 116.73% |
| Jun 30, 2015 | 69.72% |
| Dec 31, 2014 | 71.90% |
| Sep 30, 2014 | 29.83% |
| Jun 30, 2014 | -2.72% |
| Mar 31, 2014 | -33.44% |